Pe. Fraser et al., ALPHA-1-ANTICHYMOTRYPSIN BINDING TO ALZHEIMER A-BETA PEPTIDES IS SEQUENCE-SPECIFIC AND INDUCES FIBRIL DISAGGREGATION INVITRO, Journal of neurochemistry, 61(1), 1993, pp. 298-305
The serine protease inhibitor alpha1-antichymotrypsin (ACT) consistent
ly colocalizes with amyloid deposits of Alzheimer's disease (AD) and m
ay contribute to the generation of amyloid proteins and/or physically
affect fibril assembly. AD amyloid fibrils are composed primarily of A
beta, which is a proteolytic fragment of the larger beta-amyloid precu
rsor protein. Using negative-stain and immunochemical electron microsc
opy, we have investigated the binding of ACT to the fibrils formed by
four synthetic Abeta analogues corresponding to the wild-type human 1-
40 sequence [H(wt)(1-40)], a 1-40 peptide [H(Du)(1-40)] containing the
Glu22 --> Gln mutation found in hereditary cerebral hemorrhage with a
myloidosis of the Dutch type, the N-terminal 1-28 residues [beta(1-28)
], and an internal fragment of Abeta containing residues 1;1-28 [beta(
11-28)]. Each of these peptide analogues assembled into 70-90-angstrom
-diameter fibrils resembling native amyloid and, except for beta(11-28
), bound ACT, as indicated by the appearance of 80-1 00-angstrom globu
lar particles that adhered to preformed fibrils and that could be deco
rated with anti-ACT antibodies. Under the conditions used, ACT binding
destabilized the in vitro fibrils and produced a gradual dissolution
of the macromolecular assemblies into constituent filaments and shorte
r fragments. The internal fragment (11-28) did not exhibit ACT binding
or any structural changes. These results suggest that a specific sequ
ence likely contained within the N-terminal 1 0 residues of Abeta is r
esponsible for the formation of the ACT-amyloid complex. Although the
observed fibril disassembly is surprising in view of the notion that A
CT contributes directly to the physical process involved in amyloid fi
bril formation, the induced structural changes may expose new domains
in Abeta for additional proteolysis or for interactions with cell-surf
ace receptors.